Prostatype Genomics AB PGABF
$0.13
Last Updated: Mar 25, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Prostatype Genomics AB. Stock Analysis PGABF
United States Health Care Nano Cap Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. The firm's business model and concept is to manufacture, market and sell the Prostatype Test System as one prognostic package consisting of the Prostatype RTqPCR kit, the patient database and the evaluation software and accessories P-score. The test is supposed to check the aggressiveness of the prostate cancer in order to help clinicians and patients to make correct treatment decisions. Prostatype analyzes the gene expression in cancer cells extracted from prostate tissue and gives, in combination with an advanced algorithm and data analysis, decision support for optimal treatment of individual patients once prostate cancer has been confirmed.
Prostatype Genomics AB (PGABF) Chart
Financial Metrics & Statements of Prostatype Genomics AB (PGABF)
FAQ's for Prostatype Genomics AB (PGABF)
- As of August 2026, Prostatype Genomics AB PGABF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Prostatype Genomics AB using these criteria to determine its compliance status.
- Muslim investors may consider investing in Prostatype Genomics AB if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Prostatype Genomics AB by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Prostatype Genomics AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Prostatype Genomics AB on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Prostatype Genomics AB (PGABF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
